Hepatitis E Diagnostic Tests Market Size, Share & Trends Analysis Report By Type (ELISA HEV IgM Test, Rapid Diagnostics Test), By End-use (Hospitals, Blood Banks), By Region, And Segment Forecasts, 2025 - 2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,950	100 Pages	Grand View Research	January, 2025	GV19584343

Best Price Guarantee
Price	from $5,950
Length	100 Pages
Publisher	Grand View Research
Published Date	January, 2025
SKU	GV19584343

Table of Contents
Description

Hepatitis E Diagnostic Tests Market Trends

The global hepatitis E diagnostic tests market size was valued at USD 57.1 million in 2024 and is projected to witness a CAGR of 4.8% from 2025 to 2030. The growing prevalence of Hepatitis E globally, especially in developing regions, significantly drives the demand for diagnostic tests. As the awareness surrounding Hepatitis E increases due to public health campaigns and improved access to information, more individuals are seeking early detection and treatment. This heightened awareness is boosting the adoption of diagnostic tests, contributing to the market's expansion. Additionally, the emphasis on preventing outbreaks and improving healthcare infrastructure further stimulates the growth of the Hepatitis E diagnostic test market, with continued advancements in testing technology.

In addition, innovations in diagnostic technologies, such as advanced molecular techniques, rapid testing platforms, and point-of-care (POC) solutions, significantly enhance the detection of hepatitis E. These advancements offer faster, more accurate, cost-effective diagnostics, which are expected to increase market demand. The surge in preference for POC diagnostics, driven by the need for quick results in remote or resource-limited areas, further boosts market growth. As healthcare systems prioritize early diagnosis and timely interventions, the hepatitis E diagnostic tests market is poised for substantial expansion in the years ahead.

Global Hepatitis E Diagnostic Tests Market Report Segmentation

This report forecasts revenue and volume growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global hepatitis E diagnostic tests market report based on type, end-use, and region:

Type Outlook (Revenue, USD Million, 2018 - 2030)
ELISA HEV IgM Tests
ELISA HEV IgG Tests
Rapid Diagnostics Tests
Polymerase Chain Reaction (PCR)
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Diagnostics Laboratories
Blood Banks
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America

U.S.

Canada

Mexico

Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

Latin America

Brazil

Argentina

Middle East and Africa

South Africa

Saudi Arabia

UAE

Kuwait

Please note The report will be delivered in 2-3 business days upon order notification.

Chapter 1. Methodology and Scope: 1.1. Market Segmentation & Scope; 1.2. Segment Definitions; 1.2.1. Type; 1.2.2. End Use; 1.3. Estimates and Forecast Timeline; 1.4. Research Methodology; 1.5. Information Procurement; 1.5.1. Purchased Database; 1.5.2. GVR’s Internal Database; 1.5.3. Secondary Sources; 1.5.4. Primary Research; 1.6. Information Analysis; 1.6.1. Data Analysis Models; 1.7. Market Formulation & Data Visualization; 1.8. Model Details; 1.8.1. Commodity Flow Analysis; 1.9. List of Secondary Sources; 1.10. Objectives
Chapter 2. Executive Summary: 2.1. Market Snapshot; 2.2. Segment Snapshot; 2.3. Competitive Landscape Snapshot
Chapter 3. Hepatitis E Diagnostic Tests Market Variables, Trends, & Scope: 3.1. Market Lineage Outlook; 3.2. Market Dynamics; 3.2.1. Market Driver Analysis; 3.2.2. Market Restraint Analysis; 3.3. Business Environment Analysis; 3.3.1. Industry Analysis - Porter’s Five Forces Analysis; 3.3.1.1. Supplier power; 3.3.1.2. Buyer power; 3.3.1.3. Substitution threat; 3.3.1.4. Threat of new entrant; 3.3.1.5. Competitive rivalry; 3.3.2. PESTLE Analysis
Chapter 4. Hepatitis E Diagnostic Tests Market: Type Business Analysis: 4.1. Type Market Share, 2024 & 2030; 4.2. Type Segment Dashboard; 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million); 4.4. ELISA HEV IgM Tests; 4.4.1. ELISA HEV IgM Tests Market, 2018 - 2030 (USD Million); 4.5. ELISA HEV IgG Tests; 4.5.1. ELISA HEV IgG Tests Market, 2018 - 2030 (USD Million); 4.6. Rapid Diagnostics Tests; 4.6.1. Rapid Diagnostics Tests Market, 2018 - 2030 (USD Million); 4.7. Polymerase Chain Reaction (PCR); 4.7.1. Polymerase Chain Reaction (PCR) Market, 2018 - 2030 (USD Million)
Chapter 5. Hepatitis E Diagnostic Tests Market: End Use Business Analysis: 5.1. End Use Market Share, 2024 & 2030; 5.2. End Use Segment Dashboard; 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million); 5.4. Hospitals; 5.4.1. Hospitals market, 2018 - 2030 (USD Million); 5.5. Diagnostics Laboratories; 5.5.1. Diagnostics Laboratories Market, 2018 - 2030 (USD Million); 5.6. Blood Banks; 5.6.1. Blood Banks Market, 2018 - 2030 (USD Million); 5.7. Others; 5.7.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Hepatitis E Diagnostic Tests Market: Regional Estimates & Trend Analysis: 6.1. Regional Market Share Analysis, 2024 & 2030; 6.2. Regional Market Dashboard; 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:; 6.4. North America; 6.4.1. North America Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.4.2. U.S.; 6.4.2.1. Key Country Dynamics; 6.4.2.2. Regulatory Framework; 6.4.2.3. Competitive Insights; 6.4.2.4. U.S. Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.4.3. Canada; 6.4.3.1. Key Country Dynamics; 6.4.3.2. Regulatory Framework; 6.4.3.3. Competitive Insights; 6.4.3.4. Canada Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.4.4. Mexico; 6.4.4.1. Key Country Dynamics; 6.4.4.2. Regulatory Framework; 6.4.4.3. Competitive Insights; 6.4.4.4. Mexico Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.5. Europe; 6.5.1. Europe Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.5.2. UK; 6.5.2.1. Key Country Dynamics; 6.5.2.2. Regulatory Framework; 6.5.2.3. Competitive Insights; 6.5.2.4. UK Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.5.3. Germany; 6.5.3.1. Key Country Dynamics; 6.5.3.2. Regulatory Framework; 6.5.3.3. Competitive Insights; 6.5.3.4. Germany Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.5.4. France; 6.5.4.1. Key Country Dynamics; 6.5.4.2. Regulatory Framework; 6.5.4.3. Competitive Insights; 6.5.4.4. France Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.5.5. Italy; 6.5.5.1. Key Country Dynamics; 6.5.5.2. Regulatory Framework; 6.5.5.3. Competitive Insights; 6.5.5.4. Italy Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.5.6. Spain; 6.5.6.1. Key Country Dynamics; 6.5.6.2. Regulatory Framework; 6.5.6.3. Competitive Insights; 6.5.6.4. Spain Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.5.7. Denmark; 6.5.7.1. Key Country Dynamics; 6.5.7.2. Regulatory Framework; 6.5.7.3. Competitive Insights; 6.5.7.4. Denmark Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.5.8. Sweden; 6.5.8.1. Key Country Dynamics; 6.5.8.2. Regulatory Framework; 6.5.8.3. Competitive Insights; 6.5.8.4. Norway Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.5.9. Norway; 6.5.9.1. Key Country Dynamics; 6.5.9.2. Regulatory Framework; 6.5.9.3. Competitive Insights; 6.5.9.4. Sweden Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.6. Asia Pacific; 6.6.1. Asia Pacific Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.6.2. Japan; 6.6.2.1. Key Country Dynamics; 6.6.2.2. Regulatory Framework; 6.6.2.3. Competitive Insights; 6.6.2.4. Japan Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.6.3. China; 6.6.3.1. Key Country Dynamics; 6.6.3.2. Regulatory Framework; 6.6.3.3. Competitive Insights; 6.6.3.4. China Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.6.4. India; 6.6.4.1. Key Country Dynamics; 6.6.4.2. Regulatory Framework; 6.6.4.3. Competitive Insights; 6.6.4.4. India Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.6.5. Australia; 6.6.5.1. Key Country Dynamics; 6.6.5.2. Regulatory Framework; 6.6.5.3. Competitive Insights; 6.6.5.4. South Korea Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.6.6. South Korea; 6.6.6.1. Key Country Dynamics; 6.6.6.2. Regulatory Framework; 6.6.6.3. Competitive Insights; 6.6.6.4. Australia Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.6.7. Thailand; 6.6.7.1. Key Country Dynamics; 6.6.7.2. Regulatory Framework; 6.6.7.3. Competitive Insights; 6.6.7.4. Thailand Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.7. Latin America; 6.7.1. Latin America Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.7.2. Brazil; 6.7.2.1. Key Country Dynamics; 6.7.2.2. Regulatory Framework; 6.7.2.3. Competitive Insights; 6.7.2.4. Brazil Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.7.3. Argentina; 6.7.3.1. Key Country Dynamics; 6.7.3.2. Regulatory Framework; 6.7.3.3. Competitive Insights; 6.7.3.4. Argentina Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.8. MEA; 6.8.1. MEA Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.8.2. South Africa; 6.8.2.1. Key Country Dynamics; 6.8.2.2. Regulatory Framework; 6.8.2.3. Competitive Insights; 6.8.2.4. South Africa Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.8.3. Saudi Arabia; 6.8.3.1. Key Country Dynamics; 6.8.3.2. Regulatory Framework; 6.8.3.3. Competitive Insights; 6.8.3.4. Saudi Arabia Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.8.4. UAE; 6.8.4.1. Key Country Dynamics; 6.8.4.2. Regulatory Framework; 6.8.4.3. Competitive Insights; 6.8.4.4. UAE Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million); 6.8.5. Kuwait; 6.8.5.1. Key Country Dynamics; 6.8.5.2. Regulatory Framework; 6.8.5.3. Competitive Insights; 6.8.5.4. Kuwait Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape: 7.1. Participant Overview; 7.2. Company Market Position Analysis; 7.3. Company Categorization; 7.4. Strategy Mapping; 7.5. Company Profiles/Listing; 7.5.1. Wantai BioPharm; 7.5.1.1. Overview; 7.5.1.2. Financial Performance; 7.5.1.3. Product Benchmarking; 7.5.1.4. Strategic Initiatives; 7.5.2. MP Biomedicals LLP; 7.5.2.1. Overview; 7.5.2.2. Financial Performance; 7.5.2.3. Product Benchmarking; 7.5.2.4. Strategic Initiatives; 7.5.3. PerkinElmer, Inc; 7.5.3.1. Overview; 7.5.3.2. Financial Performance; 7.5.3.3. Product Benchmarking; 7.5.3.4. Strategic Initiatives; 7.5.4. Dia.Pro Diagnostic Bioprobes srl; 7.5.4.1. Overview; 7.5.4.2. Financial Performance; 7.5.4.3. Product Benchmarking; 7.5.4.4. Strategic Initiatives; 7.5.5. ELITechGroup; 7.5.5.1. Overview; 7.5.5.2. Financial Performance; 7.5.5.3. Product Benchmarking; 7.5.5.4. Strategic Initiatives; 7.5.6. Primerdesign Ltd; 7.5.6.1. Overview; 7.5.6.2. Financial Performance; 7.5.6.3. Product Benchmarking; 7.5.6.4. Strategic Initiatives; 7.5.7. F. Hoffmann-La Roche Ltd; 7.5.7.1. Overview; 7.5.7.2. Financial Performance; 7.5.7.3. Product Benchmarking; 7.5.7.4. Strategic Initiatives; 7.5.8. Mikrogen GmbH; 7.5.8.1. Overview; 7.5.8.2. Financial Performance; 7.5.8.3. Product Benchmarking; 7.5.8.4. Strategic Initiatives; 7.5.9. Altona Diagnostics; 7.5.9.1. Overview; 7.5.9.2. Financial Performance; 7.5.9.3. Product Benchmarking; 7.5.9.4. Strategic Initiatives; 7.5.10. Fortress Diagnostics; 7.5.10.1. Overview; 7.5.10.2. Financial Performance; 7.5.10.3. Product Benchmarking; 7.5.10.4. Strategic Initiatives